TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ADMA

ADMA Biologics Inc - Common Stock

NASDAQ
$13.56
▲ $2.88 (+27.0%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 18 Nov 2026
H $14.20L $7.45+59.5%
$14.2$12.85$11.5$10.15$8.8$7.45$13.56
RSI (14)
Intraday · 15-minSell-15RSI 41SidewaysMACD Bearishfor day-trading context — not advice

Technical signal

Strong buy+60
RSI (14)68
oversold 30overbought 70
Trend
Uptrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
above
vs 200-day
above
Support
$10.25
Resistance
$14.20
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2026-02-18 → 2026-11-18

Strategy return
+35.0%
Buy & hold
-15.2%
Trades
4
Win rate
50%

$100,000.00 invested would be worth $135,024.14 (+35.0%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About ADMA Biologics, Inc.· Biotechnology

source: yahoo

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Sector
Healthcare
Industry
Biotechnology
Employees
640
Headquarters
Ramsey, United States
www.admabiologics.com ↗

Fundamentals

source: yahoo
Market cap
$2.92B
P/E
17.1
P/B
6.7
EPS
$0.77
Div yield
0.0%
Profit margin
35.1%
ROE
41.9%
Debt / Equity
0.46
Beta
0.66
52-week range
$7.21 – $20.46
52-week low · $7.2148% of rangehigh · $20.46

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive4↑ · 0↓ · 4–
  • ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?▲ Positive
    Zacks · 11 Nov 2026
  • Top 3 Healthcare Stocks To Watch In November 2026— Neutral
    Simply Wall St. · 07 Nov 2026
  • Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average— Neutral
    Zacks · 06 Nov 2026
  • Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

— Neutral
Zacks · 06 Nov 2026
  • Q3 Earnings Beat Might Change The Case For ADMA Biologics Stock▲ Positive
    Simply Wall St. · 06 Nov 2026
  • ADMA Biologics (ADMA) Q3 2026 Earnings Call Transcript— Neutral
    Motley Fool · 05 Nov 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.